Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CRISPR Therapeutics
CRSP
$4.88B
| $10.2M | ﹤0.01% |
66,564
+32,291
| +94% | +$3.82M |
|
2502
PUT
Enbridge
ENB
$118B
| $10.2M | ﹤0.01% |
318,300
+105,700
| +50% | +$3.22M |
|
2503
PUT
Chemours
CC
$2.57B
| $10.2M | ﹤0.01% |
410,200
+600
| +0.1% | +$14.3K |
|
2504
PUT
Rithm Capital
RITM
$5.62B
| $10.2M | ﹤0.01% |
1,023,000
+315,700
| +45% | +$2.79M |
|
2505
Lightspeed Commerce
LSPD
$1.33B
| $10.1M | ﹤0.01% |
144,161
-386,311
| -73% | -$17.9M |
|
|
GNRS
2506
DELISTED
Greenrose Acquisition Corp. Common Stock
GNRS
| $10.1M | ﹤0.01% |
+1,000,009
| New | +$9.88M |
|
2507
CALL
Canadian Natural Resources
CNQ
$96.7B
| $10.1M | ﹤0.01% |
859,682
+539,292
| +168% | +$5.42M |
|
2508
PUT
Travelers Companies
TRV
$78B
| $10.1M | ﹤0.01% |
72,100
-44,000
| -38% | -$5.65M |
|
2509
GrafTech
EAF
$195M
| $10.1M | ﹤0.01% |
94,848
+63,368
| +201% | +$5.09M |
|
2510
PUT
EPAM Systems
EPAM
$5.6B
| $10.1M | ﹤0.01% |
28,200
+3,200
| +13% | +$1.07M |
|
|
GOCO
2511
DELISTED
GoHealth
GOCO
| $10.1M | ﹤0.01% |
49,274
+47,196
| +2,271% | +$8.77M |
|
2512
Schwab Fundamental International Small Company Index ETF
FNDC
$3.07B
| $10.1M | ﹤0.01% |
+290,223
| New | +$9.38M |
|
2513
CALL
Brinker International
EAT
$9.66B
| $10.1M | ﹤0.01% |
178,300
-64,700
| -27% | -$3.2M |
|
2514
PUT
Takeda Pharmaceutical
TAK
$53.7B
| $10.1M | ﹤0.01% |
553,397
+40,497
| +8% | +$711K |
|
|
SWAV
2515
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $10.1M | ﹤0.01% |
97,100
+56,200
| +137% | +$4.87M |
|
2516
PUT
Equity Residential
EQR
$25.3B
| $10M | ﹤0.01% |
169,400
+45,300
| +37% | +$2.56M |
|
2517
PUT
Nokia
NOK
$52.3B
| $10M | ﹤0.01% |
2,567,900
-283,700
| -10% | -$1.12M |
|
2518
PUT
Workhorse Group
WKHS
$34M
| $10M | ﹤0.01% |
169
-3
| -2% | -$195K |
|
2519
PUT
ARK Blockchain & Fintech Innovation ETF
ARKF
$726M
| $10M | ﹤0.01% |
201,800
+191,600
| +1,878% | +$8.64M |
|
2520
CALL
Axsome Therapeutics
AXSM
$10.9B
| $10M | ﹤0.01% |
123,100
-40,900
| -25% | -$3.06M |
|
2521
CALL
CleanSpark
CLSK
$3.76B
| $10M | ﹤0.01% |
344,900
+205,800
| +148% | +$2.62M |
|
2522
CALL
Churchill Downs
CHDN
$5.82B
| $9.99M | ﹤0.01% |
102,600
-16,800
| -14% | -$1.53M |
|
|
HZNP
2523
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.99M | ﹤0.01% |
136,600
+9,900
| +8% | +$736K |
|
2524
CALL
Annaly Capital Management
NLY
$17.2B
| $9.99M | ﹤0.01% |
295,475
-184,825
| -38% | -$5.72M |
|
2525
PennyMac Financial
PFSI
$3.97B
| $9.97M | ﹤0.01% |
152,004
-167,890
| -52% | -$9.99M |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.